• Science & Technology

An unexpected find: clues about the genetics of children’s cancer found in the placenta

Scientists at the Wellcome Sanger Institute have discovered that that genetic structure of the placenta contains many of the same genetic mutations found in children's cancers. Scientists at the Wellcome Sanger Institute have discovered that that genetic structure of the placenta contains many of the same genetic mutations found in children's cancers.

6 April 2021

• Science & Technology
• Health & Medicine

Predicting future breast cancer with precision

An international team of Cancer Grand Challenges scientists are conducting one biggest studies of its kind to try to predict who will develop invasive breast cancer. An international team of Cancer Grand Challenges scientists are conducting one biggest studies of its kind to try to predict who will develop invasive breast cancer.

22 March 2021

• Science & Technology

Meet the teams tackling 5 challenges in children’s and young people’s cancers

Joining forces with Children with Cancer UK, we’re proud to be co-funding the Cancer Research UK–Children with Cancer UK Innovation Awards. Joining forces with Children with Cancer UK, we’re proud to be co-funding the Cancer Research UK–Children with Cancer UK Innovation Awards.

18 March 2021

• Science & Technology

Changes detected in BRCA1 breast cells before they turn cancerous

Scientists have mapped out some of the earliest changes that occur in seemingly healthy breast tissue long before any tumours appear. Scientists have mapped out some of the earliest changes that occur in seemingly healthy breast tissue long before any tumours appear.

8 March 2021

• Science & Technology
• Health & Medicine

How repurposing a drug in a COVID-19 trial could benefit people with cancer

We spoke with Professor Kev Dhaliwal, chief investigator of the SPIKE-1 trial, about how repurposing a drug in a COVID-19 trial could benefit people with cancer. We spoke with Professor Kev Dhaliwal, chief investigator of the SPIKE-1 trial, about how repurposing a drug in a COVID-19 trial could benefit people with cancer.

2 March 2021

• Science & Technology

Antibiotic shows potential in helping treat aggressive blood cancer

New research shows a type of aggressive blood cancer could be made more sensitive to chemotherapy using an antibiotic currently available to treat diarrhoea. New research shows a type of aggressive blood cancer could be made more sensitive to chemotherapy using an antibiotic currently available to treat diarrhoea.

24 February 2021

• Science & Technology

Gentle regular exercise could reduce the risk of liver cancer in mice

A team of Cancer Research UK-funded scientists have been investigating the role of exercise in reducing the risk of liver cancer in mice A team of Cancer Research UK-funded scientists have been investigating the role of exercise in reducing the risk of liver cancer in mice

15 February 2021

• Science & Technology
• Health & Medicine

Genetic changes in tumours may predict who will respond to immunotherapy

Genetic changes in tumours could be used to predict who will benefit from immunotherapy, and who should receive other treatments.  Genetic changes in tumours could be used to predict who will benefit from immunotherapy, and who should receive other treatments. 

27 January 2021

• Science & Technology
• Health & Medicine

Discovering the BRCA2 gene – 25 years on

25 years ago, a team of our scientists were celebrating. Their risky strategy had paid off. 25 years ago, a team of our scientists were celebrating. Their risky strategy had paid off.

14 January 2021

• Science & Technology

Scientists develop approach for exploiting cancer’s dietary demands

Scientists discover a way to target cancer’s nutritional needs, which could lead to a new way to treat the disease. Scientists discover a way to target cancer’s nutritional needs, which could lead to a new way to treat the disease.

13 January 2021

• Science & Technology
• Policy & Insight

We have a Deal: What does the new UK-EU relationship mean for cancer?

Here’s what we know about how the new UK-EU relationship may affect cancer services and research. Here’s what we know about how the new UK-EU relationship may affect cancer services and research.

4 January 2021

• Science & Technology

Scientists develop new drug that targets pathway found in several hard-to-treat cancers

After decades of no luck, scientists have finally found a way to target the KRAS mutation - a common mutation found in several hard-to-treat cancers. After decades of no luck, scientists have finally found a way to target the KRAS mutation - a common mutation found in several hard-to-treat cancers.

30 December 2020